Search hospitals > California > Palo Alto
Byers Eye Institute at Stanford
Claim this profilePalo Alto, California 94303
Conducts research for Age-Related Macular Degeneration
Conducts research for Near-sightedness
Conducts research for Glaucoma
Conducts research for Macular Edema
Conducts research for Melanoma
44 reported clinical trials
8 medical researchers
Summary
Byers Eye Institute at Stanford is a medical facility located in Palo Alto, California. This center is recognized for care of Age-Related Macular Degeneration, Near-sightedness, Glaucoma, Macular Edema, Melanoma and other specialties. Byers Eye Institute at Stanford is involved with conducting 44 clinical trials across 67 conditions. There are 8 research doctors associated with this hospital, such as Theodore Leng, MD, Charles C Lin, MD, Andrea Kossler, and Prithvi Mruthyunjaya, MD.Area of expertise
1Age-Related Macular Degeneration
Stage I
CFI positive
Stage II
2Near-sightedness
Top PIs
Theodore Leng, MDStanford Medicine Ophthalmology3 years of reported clinical research
Studies Swelling
Studies Macular Edema
4 reported clinical trials
3 drugs studied
Charles C Lin, MDStanford University7 years of reported clinical research
Studies Fuchs' Dystrophy
Studies Herpes
3 reported clinical trials
6 drugs studied
Andrea KosslerStanford University2 years of reported clinical research
Studies Graves' Eye Disease
Studies Graves' Ophthalmopathy
2 reported clinical trials
2 drugs studied
Prithvi Mruthyunjaya, MDByers Eye Institute at Stanford University4 years of reported clinical research
Studies Melanoma
Studies Uveal Melanoma
1 reported clinical trial
1 drug studied
Clinical Trials running at Byers Eye Institute at Stanford
Fuchs' Dystrophy
Corneal Dystrophies
Glaucoma
Cataract
Uveitis
Uveitis-Related Macular Edema
Macular Edema
Swelling
Cystoid Macular Edema
Scleritis
K-321 Eye Drops
for Fuchs' Dystrophy
This trial is testing K-321 to see if it helps people with FECD recover better after cataract surgery and descemetorhexis by supporting the healing of their cornea. K-321 has shown promise in treating corneal conditions like Fuchs' Endothelial Corneal Dystrophy (FECD).
Recruiting1 award Phase 33 criteria
K-321 Eye Drops
for Fuchs' Dystrophy
This trial is testing K-321 to help people with an eye condition called FECD recover after a corneal procedure. The treatment aims to support the growth and repair of eye cells.
Recruiting1 award Phase 3
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Byers Eye Institute at Stanford?
Byers Eye Institute at Stanford is a medical facility located in Palo Alto, California. This center is recognized for care of Age-Related Macular Degeneration, Near-sightedness, Glaucoma, Macular Edema, Melanoma and other specialties. Byers Eye Institute at Stanford is involved with conducting 44 clinical trials across 67 conditions. There are 8 research doctors associated with this hospital, such as Theodore Leng, MD, Charles C Lin, MD, Andrea Kossler, and Prithvi Mruthyunjaya, MD.